-
Je něco špatně v tomto záznamu ?
Deroofing followed by thorough sinus tract excision: a modified surgical approach for hidradenitis suppurativa
RA. Dahmen, S. Gkalpakiotis, L. Mardesicova, P. Arenberger, M. Arenbergerova,
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články
PubMed
31219670
DOI
10.1111/ddg.13875
Knihovny.cz E-zdroje
- MeSH
- axila MeSH
- chirurgie operační škodlivé účinky metody MeSH
- debridement škodlivé účinky metody MeSH
- dospělí MeSH
- hidradenitis suppurativa patologie chirurgie MeSH
- hojení ran fyziologie MeSH
- inguinální kanál MeSH
- lidé MeSH
- pooperační komplikace epidemiologie MeSH
- pooperační krvácení epidemiologie MeSH
- prospektivní studie MeSH
- recidiva MeSH
- stupeň závažnosti nemoci MeSH
- subjekt ztracen ze sledování MeSH
- vizuální analogová stupnice MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Česká republika MeSH
BACKGROUND AND OBJECTIVES: Deroofing has proven to be an effective method to treat mild to moderate forms of hidradenitis suppurativa (HS). The basic procedure includes removal of the sinus roof, followed by secondary intention healing, while fibrotic tissue usually stays in situ. We have tried to establish a modified method of deroofing in which meticulous removal of the fibrotic tissue results in a low recurrence rate in moderate to severe HS patients. PATIENTS AND METHODS: An open prospective study consisted of 96 deroofed lesions in 52 consecutive patients with moderate to severe HS. Patients were followed up for a minimum of 28 months. RESULTS: Recurrence occurred after a median time of 2.3 months in 14 % of locations. Recurrences according to location were as follows: 6 % in the axillary region and 25 % in the inguinal region. Postoperative bleeding was the only considerable complication and occurred in 7 % of treated locations. Seven patients were lost to follow-up. CONCLUSION: Modified deroofing followed by meticulous sinus tract removal is a surgical approach suitable for patients with moderate disease, especially in the axillary region. This results in a low recurrence rate and the same healing period as that of the standard deroofing procedure.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20006233
- 003
- CZ-PrNML
- 005
- 20200526094546.0
- 007
- ta
- 008
- 200511s2019 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/ddg.13875 $2 doi
- 035 __
- $a (PubMed)31219670
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Dahmen, Robert Artur $u Department of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic.
- 245 10
- $a Deroofing followed by thorough sinus tract excision: a modified surgical approach for hidradenitis suppurativa / $c RA. Dahmen, S. Gkalpakiotis, L. Mardesicova, P. Arenberger, M. Arenbergerova,
- 520 9_
- $a BACKGROUND AND OBJECTIVES: Deroofing has proven to be an effective method to treat mild to moderate forms of hidradenitis suppurativa (HS). The basic procedure includes removal of the sinus roof, followed by secondary intention healing, while fibrotic tissue usually stays in situ. We have tried to establish a modified method of deroofing in which meticulous removal of the fibrotic tissue results in a low recurrence rate in moderate to severe HS patients. PATIENTS AND METHODS: An open prospective study consisted of 96 deroofed lesions in 52 consecutive patients with moderate to severe HS. Patients were followed up for a minimum of 28 months. RESULTS: Recurrence occurred after a median time of 2.3 months in 14 % of locations. Recurrences according to location were as follows: 6 % in the axillary region and 25 % in the inguinal region. Postoperative bleeding was the only considerable complication and occurred in 7 % of treated locations. Seven patients were lost to follow-up. CONCLUSION: Modified deroofing followed by meticulous sinus tract removal is a surgical approach suitable for patients with moderate disease, especially in the axillary region. This results in a low recurrence rate and the same healing period as that of the standard deroofing procedure.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a axila $7 D001365
- 650 _2
- $a debridement $x škodlivé účinky $x metody $7 D003646
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a hidradenitis suppurativa $x patologie $x chirurgie $7 D017497
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a inguinální kanál $7 D007264
- 650 _2
- $a subjekt ztracen ze sledování $7 D059012
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a pooperační komplikace $x epidemiologie $7 D011183
- 650 _2
- $a pooperační krvácení $x epidemiologie $7 D019106
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a recidiva $7 D012008
- 650 _2
- $a stupeň závažnosti nemoci $7 D012720
- 650 _2
- $a chirurgie operační $x škodlivé účinky $x metody $7 D013514
- 650 _2
- $a vizuální analogová stupnice $7 D064232
- 650 _2
- $a hojení ran $x fyziologie $7 D014945
- 651 _2
- $a Česká republika $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Gkalpakiotis, Spyridon $u Department of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic.
- 700 1_
- $a Mardesicova, Libuse $u Department of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic.
- 700 1_
- $a Arenberger, Petr $u Department of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic.
- 700 1_
- $a Arenbergerova, Monika $u Department of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic.
- 773 0_
- $w MED00007450 $t Journal der Deutschen Dermatologischen Gesellschaft Journal of the German Society of Dermatology : JDDG $x 1610-0387 $g Roč. 17, č. 7 (2019), s. 698-702
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31219670 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200511 $b ABA008
- 991 __
- $a 20200526094543 $b ABA008
- 999 __
- $a ok $b bmc $g 1525091 $s 1096289
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 17 $c 7 $d 698-702 $e 20190620 $i 1610-0387 $m Journal der Deutschen Dermatologischen Gesellschaft $n J Dtsch Dermatol Ges $x MED00007450
- LZP __
- $a Pubmed-20200511